PHA to Host Facebook Live Mini-Concert to Raise Awareness of PH

What: The Pulmonary Hypertension Association (PHA) will present a live mini-concert to bring awareness to pulmonary hypertension (PH), a progressive, life-threatening disease often misdiagnosed – as asthma, for example. The three-minute concert, followed by a brief Q & A session, will feature Chloe Temtchine -- propelled to YouTube fame as a vocalist, guitarist and

May 18th, 2017|

Researchers to Present Studies Based on Data from PHA’s Accreditation Program Registry at the American Thoracic Society Meeting

Silver Spring, Md. (May 18, 2017) –  Researchers will present two abstracts based on information from the Pulmonary Hypertension Association Registry (PHAR) at the American Thoracic Society (ATS) meeting this month. The PHAR is a part of the Pulmonary Hypertension Association (PHA) Pulmonary Hypertension Care Center (PHCC) accreditation program. Pulmonary arterial hypertension (PAH)—a progressive,

May 18th, 2017|

PHA Accredits the First Regional Clinical Programs as Part of the Pulmonary Hypertension Care Center Program

Silver Spring, Md. (May 18, 2017) –  Three pulmonary hypertension (PH) clinics have earned accreditation from the Pulmonary Hypertension Association (PHA) after demonstrating their ability to deliver quality care to patients living with a complex, often misdiagnosed, life-threatening disease. The three centers were participants in the Regional Clinical Program (RCP) pilot program, designed as

May 18th, 2017|

PHA Speaks Out on House of Representatives’ Passage of the American Health Care Act

Washington, D.C., May 5, 2017—  The Pulmonary Hypertension Association (PHA) -- the world’s first and largest organization dedicated to empowering and advocating for pulmonary hypertension (PH) patients and caregivers, promoting quality care and catalyzing research for a cure -- issued a response to the House of Representatives’ passage of the American Health Care Act. PHA

May 5th, 2017|

PHA Leader Gregory Elliott, M.D. Recognized for Patient Care and Research Advancements by American Thoracic Society

Silver Spring, Md. (April 20, 2017) – The Pulmonary Hypertension Association (PHA) is excited to announce that the significant contributions in advancing pulmonary hypertension (PH) care and research of C. Gregory Elliott, M.D., M.A.C.P., have earned him the 2017 American Thoracic Society Public Advisory Roundtable (PAR) William J. Martin, II Distinguished Achievement Award. Dr. Elliott,

April 20th, 2017|

Pulmonary Hypertension Association Applauds First State-Appointed Pulmonary Hypertension Task Force

Silver Spring, Md. (April 13, 2017) - Instituting the nation’s first pulmonary hypertension (PH) law, Massachusetts has named the first members of a task force of experts to monitor and report annually on advances in caring for patients fighting the disease. Massachusetts Governor Charlie Baker signed the PH bill into law in January, which

April 13th, 2017|

PHA and International Groups Join Forces on May 5 in Global Social Media Awareness Campaign

Silver Spring, Md. (April 12, 2017) – The Pulmonary Hypertension Association (PHA) joins 80 global sister organizations on May 5 for Periwinkle Hearts Around the World, a worldwide campaign to raise awareness of the need for better access to care for people living with pulmonary hypertension (PH). PH is a progressive, debilitating lung disease

April 12th, 2017|

Pulmonary Hypertension Association Announces First Aldrighetti Research Award for Young Investigators Grantee

Silver Spring, Md. (April 6, 2017) –  The Pulmonary Hypertension Association (PHA) congratulates Olivier Boucherat, Ph.D., L’Université Laval in Québec, the recipient of its first Aldrighetti Research Award for Young Investigators. PHA is the world’s first and the United States’ only nonprofit provider of support and educational resources and programs for the pulmonary hypertension (PH)

April 7th, 2017|

Pulmonary Hypertension Association (PHA) Kicks Off National O2 breathe™ Fundraising Events Season to Fight Often Misdiagnosed, Misunderstood Disease

Silver Spring, Md. (March 1, 2017) – Partnering with patients and their personal and professional caregivers, the Pulmonary Hypertension Association (PHA) kicks off its 2017 National O2 breathe™ special events season to raise funds and awareness to fight an often misdiagnosed and misunderstood deadly disease. The 2017 season begins with the 2nd Annual PHA

March 2nd, 2017|